SEC Filing Analysis: CASSAVA SCIENCES INC (SAVA)

Executive Summary

• Trading Significance: Medium
• Key Takeaway: A director, Bir Dawn Carter, was granted 53,000 stock options, a standard but notable form of equity compensation that aligns insider and shareholder interests.
• Market Impact: The grant represents a minor potential dilution of 0.11% and is a neutral-to-bullish signal of long-term confidence from the board.

Company Information

Field	Value
Company	CASSAVA SCIENCES INC
Ticker Symbol	SAVA
CIK	0001069530
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	Bir Dawn Carter
CIK	0001688712
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-21
Transaction Code	A (Grant)
Security Type	Stock Option (Right to Buy)
Shares Involved	53,000
Price Per Share	$0.00
Total Value	$0
Shares Owned After	53,000 (options)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0 (Notional Value: $210,940)
% of Market Cap	0.10% (based on notional value)
Shares Transacted	53,000
% of Shares Outstanding	0.11%
Post-Transaction Ownership	53,000 options (potential 0.11% of outstanding)
Materiality Assessment	Moderate

Impact Evaluation

• Market Cap Context: For a small-cap company with a $210 million market capitalization, a stock option grant with a notional value over $200,000 is a meaningful incentive for a non-employee director.
• Ownership Concentration: This grant establishes the director's initial equity position in the form of options, aligning their financial interests with the company's future stock performance.
• Dilution Impact: The potential exercise of these 53,000 options would increase the total shares outstanding by approximately 0.11%. This is a minor dilution event and is a typical part of executive and board compensation packages.
• Transaction Significance: The significance is moderate. While the transaction value is $0, the number of underlying shares relative to the company's total shares outstanding (0.11%) and the notional value relative to its market cap (0.10%) make it a noteworthy compensation event.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral to slightly Positive
• Reasoning: Equity grants to directors are standard practice and are generally viewed as a way to align interests. The market typically does not react strongly to such events unless they are unusually large. This grant is moderately sized and signals board-level commitment.

Volume & Sentiment

• Expected Volume Impact: Low. Compensation-related grants rarely drive significant trading volume.
• Sentiment Indicator: Bullish. The grant incentivizes the director to contribute to long-term value creation, which is a positive for shareholders.

Investment Insights

Positive Market Indicators

• Insider Alignment: The grant directly ties the director's financial outcomes to the company's stock performance.
• Long-Term Incentive: The three-year vesting schedule encourages a long-term focus.

Risk Factors

• Potential Dilution: While minor, any issuance of new equity or options creates dilution for existing shareholders upon exercise.

Key Takeaways

1. A director, Bir Dawn Carter, received a grant of 53,000 stock options.
2. The grant has a notional value of approximately $210,940, representing 0.1% of the company's market cap.
3. The options vest over three years, indicating a long-term incentive structure.

Additional Context

Transaction Notes

• Vesting Schedule: The options vest monthly over a three-year period (1/36th per month), as detailed in the filing's footnote.
• Exercise Price: The options have an exercise price of $3.98, meaning they will only have intrinsic value if the company's stock price rises above this level.